Xconomy

APRIL 21, 2017

Our own reporting focused this week on the fallout from high drug prices, with a look at the frustration of families whose children have had trouble gaining access to the first drug ever approved for the rare spinal muscular atrophy. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Study 49

Study News Pricing Google 49

Xconomy

JANUARY 27, 2017

A new study showed it may take another 40 years to achieve gender diversity in life sciences. It was a wild week in biotech and on Capitol Hill. Tensions continued to mount between drugmakers and payers over the rising costs of rare disease drugs.

News 40

News Study Marketing Anthem 40

Xconomy

OCTOBER 7, 2016

—Alnylam Pharmaceuticals (NASDAQ: ALNY ) of Cambridge, MA, said that it would shelve its drug revusiran after 18 patients died in a Phase 3 study to treat the rare disease transthyretin amyloidosis. PRICE FIGHTS. With some caveats, ICER recommended lower prices. CLINICAL NEWS. —The U.S.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

DECEMBER 20, 2016

San Diego-based Acadia (NASDAQ: ACAD ) reported that patients treated in an exploratory study with its drug pimavanserin showed a statistically significant reduction in psychosis compared against a group given a placebo. Investors cheered the news, boosting Acadia’s stock price 13.6 percent to $28.88 in trading Tuesday morning.

San Diego 40

San Diego Statistics Study News 40

Xconomy

APRIL 20, 2018

The biggest news this week was in oncology, hands down. The price of drugs is certainly on a lot of minds these days, including the mind of President Trump, as he reportedly will make a. While pembrolizumab notched the headline-grabbing data, others are also working to develop options for various subsets of patients.

Pricing 52

Pricing News Report Develop 52

Xconomy

JULY 8, 2016

But the news in our little corner of the world doesn’t stop. —Another health scourge was in the news: hepatitis. British medical journal The Lancet published a study , funded by the Bill and Melinda Gates Foundation, that showed viral hepatitis has become the seventh leading cause of death globally, up from tenth in 1990.

Pricing 52

Pricing News Journal Startup 52

Xconomy

AUGUST 11, 2017

With President Trump holed up in New Jersey, rattling his saber at Kim Jong-un and Mitch McConnell and ignoring his own commission’s advice on the opioid crisis, there was still life sciences news from the nation’s capital.

Pricing 52

Pricing News Report Competition 52

Xconomy

NOVEMBER 11, 2016

Drug company stocks got a boost with the defeat of Hillary Clinton, a vocal critic of drug prices. Will he take a softer stance on drug prices? Here’s what we know: There’s news to round up. But her near doubling of Trump (62 to 33 percent) didn’t translate into support for drug price controls.

Patents 87

Patents Study Pricing Research 87

Xconomy

JUNE 10, 2016

Plans for new incubators were announced in two different cities. We’ve got those stories, plus a spate of financings and deals, a legal feud, and other news below. The new prices don’t reflect rebates and discounts. Ed Silverman at STAT reported the analyst note first.

Incubator 67

Incubator Thousand Oaks Screening Pricing 67

Both Sides of the Table

AUGUST 12, 2010

We led off with a discussion about Slide being acquired by Google, which was breaking news in the time slot where we filmed this episode. But this gets all the space on prominent blogs because it’s what bloggers like to cover.&# It’s self selecting. A recent study said seed stage valuations have been quite static recently.

Venture Capital 232

Venture Capital Slides Seed Funding Google 232

Xconomy

JULY 29, 2016

Amongst several companies to report this week, the biggest news came from Gilead Sciences (NASDAQ: GILD ), whose hepatitis C drugs have become some of the top revenue producers in the industry. The study is one of several Celgene is running to try to expand the use of its blockbuster blood cancer drug. But our minds jumped to politics.

Startup 40

Startup Study News Report 40

Xconomy

AUGUST 31, 2018

We’ll start with what was—and wasn’t—in Pfizer’s data release Monday, top up with more ATTR news, then round up a slew of drug approvals, a slug of policy news, and a welter of financings and deals. We’ve labored to gather it all so you don’t have to. Have a great weekend, everyone.

News 49

News Startup Competition San Diego 49

Xconomy

JULY 18, 2016

In early trading Monday, Evoke’s (NASDAQ: EVOK ) stock price was down 72 percent to $3.02 in New York. Evoke’s late-stage study failed to show a significant benefit to the drug, EVK-001, versus placebo at all 41 of the sites that tested it nationally. per share as of 11:30 a.m.

Study 40

Study Sites News Research 40

Xconomy

AUGUST 19, 2016

The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. —The FDA last summer approved two new cholesterol fighting drugs known as PCSK9 inhibitors, but so far the market has rejected them, resulting in paltry sales. Be our guest and try it.).

Technical Review 40

Technical Review Patents .Net Study 40

Xconomy

SEPTEMBER 16, 2016

New documents came to light that showed the sugar industry paid for studies downplaying the ties between sugar and heart disease. Meanwhile, there was yet another twist in the ongoing Duchenne muscular dystrophy drama, more biotech buyouts, new startups, and the filing of a long anticipated IPO. .

Research 40

Research Pricing News Report 40

Tech Zulu Event

NOVEMBER 18, 2011

Typically entrepreneurs doubt themselves because they undervalue their offerings, but it isn’t about creating a product, setting a price and hoping people will buy. Valu e and Exp erience versus Price and Product. Now study the event organizer. Blogs and Forums. The best place to find a directory of blogs is AllTop.

Customer 85

Customer Custom Marketing SEO 85

Both Sides of the Table

JANUARY 12, 2014

The starting point of product IS marketing, which is what a lot of young entrepreneurs that never studied business don’t realize. Product is simply about defining a physical good or service that would be valued by consumers of the product more than existing alternatives based on functionality, quality and/or price. ” Me?

Marketing 379

Marketing Startup SEM SEO 379

Xconomy

AUGUST 12, 2016

In other Google-related news, Recode reported that Bill Maris, the founder and president of Google Ventures (now called GV), has left the firm and will be replaced by David Krane. The news was a relief for Redwood City, CA-based Heron, which has been waiting for word on the status of its drug since September 2015. . —The U.S.

Google 40

Google Technical Review News Research 40

Both Sides of the Table

MAY 13, 2018

This goes into the heart of my controversial blog post (coming soon! Come back to this blog over the next 2 weeks and I’ll explain. Sometimes I encourage teams to create new analysis on cohorts, future revenue projections, competitor reviews, pricing studies, etc.

Venture Capital 332

Venture Capital Funding Startup Sales 332

Tech Zulu Event

JULY 18, 2011

Andrea: Anybody who’s looking for clothes, shoes or accessories can come to our site and put up a post of what they’re looking for with the size, price range, etc., If you are referring to the blog post about being a mom and a CEO, studies have shown that women are far better multi-taskers than men. Calm down guys.).

Startup 99

Startup Social Media Media Sites 99

Xconomy

NOVEMBER 4, 2016

Our previous roundup came out last week before news broke that Susan Lindquist, a highly decorated and thoughtful researcher into the inner workings of proteins, passed away. The Mayo Clinic cardiologist behind the report published a study earlier this year about long QT misdiagnosis leading to improper defibrillator implants.

Research 40

Research Report Pricing Journal 40

Tech Zulu Event

AUGUST 13, 2010

Removing the Middleman: Embedding Shopping on Your Blog. In 2009 my art blog www.johntunger.com earned $188,138 in gross sales from 205,839 unique visitors. Entrepreneurism / Monetization blogging, Entrepreneurship, monetization. . Entrepreneurism / Monetization blogging, e-commerce, Relationships. . Unger, John T.

Guide 69

Guide Startup Venture Capital Entrepreneur 69

Both Sides of the Table

MAY 7, 2011

Sometime around 2003/04 my technology team turned me on to “Spolsky on Software&# a periodic newsletter served up blog style from Joel Spolsky of FogCreek Software, a maker of bug-tracking software. Blogs weren’t popularized yet so it was an oddity for me to read the founder of a software company spewing out advice.

Software Review 285

Software Review Software Blogging Startup 285